Synthesis of non-natural cofactor analogs of S-adenosyl-L-methionine using methionine adenosyltransferase

US9879043B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-9879043-B1
Application numberUS-201414298874-A
CountryUS
Kind codeB1
Filing dateJun 6, 2014
Priority dateJun 6, 2013
Publication dateJan 30, 2018
Grant dateJan 30, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to the synthesis of non-natural analogs of S-adenosyl-L-methionine (SAM) and/or of Se-adenosyl-L-methionine (SeAM) by reacting a methionine analog and adenosine triphosphate (ATP) in the presence of at least one methionine adenosyltransferase (MAT), and to use thereof with downstream SAM and/or SeAM utilizing enzymes. The non-natural analogs of SAM and/or SeAM have the general formula: where X is S or Se, and R 1 is an alkyl group.

First claim

Opening claim text (preview).

What is claimed is: 1. An S-adenosyl-L-methionine (SAM) or Se-adenosyl-L-methionine (SeAM) analog of the Formula III: wherein X is selected from the group consisting of S and Se; wherein, when X is S, R 1 is selected from the group consisting of: wherein, when X is Se, R 1 is selected from the group consisting of: 2. A compound of the Formula II: wherein R 1 is selected from the group consisting of and X is S. 3. An S-adenosyl-L-methionine analog of the Formula III: wherein X is S and R 1 is selected from the group consisting of: 4. An S-adenosyl-L-methionine (SAM) analog of the formula: 5. A method of producing an S-adenosyl-L-methionine analog according to claim 4 , comprising the step of reacting a first substrate comprising methionine-tetrazole with a second substrate comprising adenosine triphosphate (ATP) in the presence of a methionine adenosyltransferase (MAT). 6. The method of claim 5 , wherein the MAT comprises at least one of human MAT II catalytic alpha and regulatory beta subunit (hMAT2), human MAT II catalytic alpha subunit alone (hMAT2A), human MAT I catalytic subunit alpha (hMAT1A), Escherichia coli MAT (eMAT), Sulfolobus solfataricus MAT (sMAT), and Methanocaldococcus jannaschii MAT (mMAT). 7. A method of producing the S-adenosyl-L-methionine analog of claim 1 , comprising the step of reacting a first substrate comprising a methionine analog with a second substrate comprising adenosine triphosphate (ATP) in the presence of a methionine adenosyltransferase (MAT). 8. The method of claim 7 , wherein the MAT comprises at least one of human MAT II catalytic alpha and regulatory beta subunit (hMAT2), human MAT II catalytic alpha subunit alone (hMAT2A), human MAT I catalytic subunit alpha (hMAT1A), Escherichia coli MAT (eMAT), Sulfolobus solfataricus MAT (sMAT), and Methanocaldococcus jannaschii MAT (mMAT). 9. The method of claim 7 , wherein the first substrate is of the Formula II: wherein R 1 is selected from the group consisting of wherein X is S. 10. A method of producing the Se-adenosyl-L-methionine analog of claim 1 , comprising the step of reacting a first substrate comprising a methionine analog with a second substrate comprising adenosine triphosphate (ATP) in the presence of a methionine adenosyltransferase (MAT). 11. The method of claim 10 , wherein the first substrate is of the Formula II: wherein R 1 is selected from the group consisting of wherein X is Se. 12. A method of producing an indolocarbazole analog, comprising the step of reacting a first substrate comprising a methionine analog with a second substrate in the presence of a methionine adenosyltransferase (MAT), wherein the methionine analog is of the Formula II: wherein R 1 is selected from the group consisting of wherein X is selected from the group consisting of S and Se; and wherein the second substrate comprises at least one indolocarbazole group. 13. The method of claim 12 , wherein the MAT comprises at least one of human MAT II catalytic alpha and regulatory beta subunit (hMAT2), human MAT II catalytic alpha subunit alone (hMAT2A), human MAT I catalytic subunit alpha (hMAT1A), Escherichia coli MAT (eMAT), Sulfolobus solfataricus MAT (sMAT), and Methanocaldococcus jannaschii MAT (mMAT).

Assignees

Inventors

Classifications

  • Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms (ergot-alcaloids C12P17/183) · CPC title

  • having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides · CPC title

  • C07H19/16Primary

    Purine radicals · CPC title

  • containing three or more hetero rings · CPC title

  • of an acyclic saturated carbon skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9879043B1 cover?
The present disclosure relates to the synthesis of non-natural analogs of S-adenosyl-L-methionine (SAM) and/or of Se-adenosyl-L-methionine (SeAM) by reacting a methionine analog and adenosine triphosphate (ATP) in the presence of at least one methionine adenosyltransferase (MAT), and to use thereof with downstream SAM and/or SeAM utilizing enzymes. The non-natural analogs of SAM and/or SeAM hav…
Who is the assignee on this patent?
Univ Kentucky Res Found
What technology area does this patent fall under?
Primary CPC classification C07H19/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).